Form 4 Tracker
BeOne Medicines Ltd.
ONC

18 insider filings · Latest: Jul 22, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 22, 2026Jul 24 8:51 PMChan Henry LeeSVP, General Counsel
Sale
1,669$325.00$542.4K0(D)

View →

Jun 8, 2026Jun 10 9:27 PMTitus B. BallPrincipal Accounting Officer
Sale
136$271.33$36.9K0(D)

View →

Jun 8, 2026Jun 10 9:26 PMChan Henry LeeSVP, General Counsel
Sale
871$270.42$235.5K0(D)

View →

Jun 8, 2026Jun 10 9:25 PMLai WangPresident, Global Head of R&D
Sale
1,367$269.38$368.2K0(D)

View →

Jun 8, 2026Jun 10 9:23 PMXiaobin WuPresident and COO
Sale
1,484$269.37$399.7K0(D)

View →

Jun 8, 2026Jun 10 9:22 PMJohn OylerDirector, Chief Executive Officer
Sale
4,940$270.56$1.3M0(D)

View →

Jun 1, 2026Jun 3 8:10 PMQingqing YiDirector
Sale
235$279.13$65.6K0(D)

View →

May 22, 2026May 27 9:29 PMAlessandro RivaDirector
Sale
212$309.51$65.6K0(D)

View →

May 22, 2026May 27 9:26 PMMargaret DuganDirector
Sale
212$309.60$65.6K0(D)

View →

May 22, 2026May 27 9:26 PMCorazon (Corsee) D. SandersDirector
Sale
212$309.59$65.6K0(D)

View →

May 22, 2026May 27 8:54 PMBAKER BROS. ADVISORS LPDirector
Sale
10,998$23.82$262.0K142,570(I)

View →

May 13, 2026May 15 8:39 PMChan Henry LeeSVP, General Counsel
Sale
332$310.72$103.2K0(D)

View →

Mar 11, 2026Mar 13 9:26 PMChan Henry LeeSVP, General Counsel
Sale
341$300.00$102.3K0(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 22, 2026Jul 24 8:51 PMChan Henry LeeSVP, General Counsel
Option Exercise
21,69798,930(D)

View →

May 13, 2026May 15 8:39 PMChan Henry LeeSVP, General Counsel
Option Exercise
4,316107,848(D)

View →

Mar 11, 2026Mar 13 9:26 PMChan Henry LeeSVP, General Counsel
Option Exercise
4,433110,396(D)

View →